Tenax Therapeutics
TENX
105 hedge funds and large institutions have $60.4M invested in Tenax Therapeutics in 2026 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 36 closing their positions.
588% more call options, than puts
Call options by funds: $3.89M | Put options by funds: $566K
67% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 21
4.3% more ownership
Funds ownership: 81.07% → 85.37% (+4.3%)
6% less funds holding
Funds holding: 112 → 105 (-7)
14% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 36
21% less capital inflows, than outflows
Capital inflows: $133M | Capital outflows: $170M
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ADAR1 Capital Management
Austin,
Texas
|
+$47.5M |
| 2 |
Sphera Funds Management
Tel Aviv,
Israel
|
+$16.5M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$9.43M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$8.99M |
| 5 |
BlackRock
New York
|
+$8.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$25.7M |
| 2 |
Perceptive Advisors
New York
|
-$24.7M |
| 3 |
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$10.9M |
| 4 |
RTW Investments
New York
|
-$10.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$8.1M |
TENX Hedge Fund Activity: Q3 2026 in Review
105 of the 8,114 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2026, worth a combined $60.4M — down 86% from $441M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of TENX and 31 opened new positions — a net loss of 5 holders — while 21 trimmed existing stakes and 35 added.
The largest buyer was ADAR1 Capital Management, adding an estimated $47.5M. The largest seller was Fidelity Investments, cutting an estimated $25.7M.
- 105 institutional investors held Tenax Therapeutics (TENX) as of Q3 2026, down from 112 in Q2 2026.
- Funds reported $60.4M of Tenax Therapeutics stock for Q3 2026, down 86% quarter-over-quarter.
- 31 funds opened new Tenax Therapeutics positions in Q3 2026 and 36 closed out, a net change of -5 holders.
- The largest Tenax Therapeutics buyer in Q3 2026 was ADAR1 Capital Management, an estimated $47.5M added.
- The largest Tenax Therapeutics seller in Q3 2026 was Fidelity Investments, an estimated $25.7M sold.
Based on aggregated 13F filings for Q3 2026.